Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Quality Alerts: FDA Issues Form 483 to Dr. Reddy's Laboratories Duvvada India - Dr. Reddy\'s Laboratories

Dr. Reddy's Laboratories

Uploaded: 2018

Henlius & Dr. Reddy's Ink Licensing Deal for HLX15 Expansion in Europe & US

07 Feb 2025

// PRESS RELEASE

Indian drugmaker Dr Reddy's shares slide after Q3 profit miss

24 Jan 2025

// PRESS RELEASE

Dr. Reddy`s Generics Sitagliptin Receive Tentative Approval in US

16 Jan 2025

// FDA

DATA COMPILATION
#PharmaFlow

DRL

Contact Supplier

BioAsia

Attending

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

https://www.youtube.com/embed/cIxfnsaeBmc

Xls

CATEGORY PAGE

Dr. Reddy's Laboratories

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2024, Corporate Presentation, API Product List 2024, Products Under Development 2024, FDF Product List 2024, GMP Certificate 2024

Product List 2024
Corporate Presentation
API Product List 2024
Products Under Development 2024
FDF Product List 2024
GMP Certificate 2024

VIDEO(s)

Your Partner for High-Quality & Cost-effective APIs, Dr. Reddy's - About Us

Your Partner for High-Quality & Cost-effective APIs
Dr. Reddy's - About Us

DIGITAL CONTENT

1 VLOG #PharmaReel, 8 CORPORATE CONTENT #SupplierSpotlight, 7 DATA COMPILATION #PharmaFlow, 1080 NEWS #PharmaBuzz

1 VLOG #PharmaReel
8 CORPORATE CONTENT #SupplierSpotlight
7 DATA COMPILATION #PharmaFlow
1080 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

237 All APIs, 161 USDMF, 50 CEP/COS, 31 JDMF, 135 EU WC, 151 KDMF, 183 NDC API, 147 Listed APIs

237 All APIs
161 USDMF
50 CEP/COS
31 JDMF
135 EU WC
151 KDMF
183 NDC API
147 Listed APIs

DEVELOPMENTS

139 Drugs in Development

139 Drugs in Development

FINISHED DOSAGE FORMULATIONS

808 FDF Dossiers, 575 FDA Orange Book, 10 Europe, 223 Listed Dossiers

808 FDF Dossiers
575 FDA Orange Book
10 Europe
223 Listed Dossiers

KEY PRODUCTS

Apixaban, Capecitabine, Carfilzomib, Dabigatran Etexilate Mesylate, Dapagliflozin, Dapagliflozin Propanediol Monohydrate, Empagliflozin, Enzalutamide, Eribulin, Ferric Carboxymaltose, Glatiramer Acetate, Iron Sucrose, Mirabegron, Nilotinib, Olaparib, Palbociclib, Quetiapine Hemifumarate, Rivaroxaban, Sacubitril-Valsartan, Sitagliptin Hydrochloride, Sitagliptin Malate, Sitagliptin Phosphate, Sugammadex Sodium

Apixaban
Capecitabine
Carfilzomib
Dabigatran Etexilate Mesylate
Dapagliflozin
Dapagliflozin Propanediol Monohydrate
Empagliflozin
Enzalutamide
Eribulin
Ferric Carboxymaltose
Glatiramer Acetate
Iron Sucrose
Mirabegron
Nilotinib
Olaparib
Palbociclib
Quetiapine Hemifumarate
Rivaroxaban
Sacubitril-Valsartan
Sitagliptin Hydrochloride
Sitagliptin Malate
Sitagliptin Phosphate
Sugammadex Sodium

EXCIPIENTS

1 All Excipients, 1 USDMF

1 All Excipients
1 USDMF

INSPECTIONS & REGISTRATIONS

66 FDA, 37 EDQM, 18 GDUFA

66 FDA
37 EDQM
18 GDUFA

PC100302

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?